Oligomerization of membrane proteins in response to lipid binding has a critical role in many cell-signalling pathways 1 but is often difficult to define 2 or predict 3 . Here we report the development of a mass spectrometry platform to determine simultaneously the presence of interfacial lipids and oligomeric stability and to uncover how lipids act as key regulators of membrane-protein association. Evaluation of oligomeric strength for a dataset of 125 α-helical oligomeric membrane proteins reveals an absence of interfacial lipids in the mass spectra of 12 membrane proteins with high oligomeric stability. For the bacterial homologue of the eukaryotic biogenic transporters (LeuT 4 , one of the proteins with the lowest oligomeric stability), we found a precise cohort of lipids within the dimer interface. Delipidation, mutation of lipid-binding sites or expression in cardiolipin-deficient Escherichia coli abrogated dimer formation. Molecular dynamics simulation revealed that cardiolipin acts as a bidentate ligand, bridging across subunits. Subsequently, we show that for the Vibrio splendidus sugar transporter SemiSWEET 5 , another protein with low oligomeric stability, cardiolipin shifts the equilibrium from monomer to functional dimer. We hypothesized that lipids are essential for dimerization of the Na + /H + antiporter NhaA from E. coli, which has the lowest oligomeric strength, but not for the substantially more stable homologous Thermus thermophilus protein NapA. We found that lipid binding is obligatory for dimerization of NhaA, whereas NapA has adapted to form an interface that is stable without lipids. Overall, by correlating interfacial strength with the presence of interfacial lipids, we provide a rationale for understanding the role of lipids in both transient and stable interactions within a range of α-helical membrane proteins, including G-protein-coupled receptors.
/H
+ antiporter NhaA from E. coli, which has the lowest oligomeric strength, but not for the substantially more stable homologous Thermus thermophilus protein NapA. We found that lipid binding is obligatory for dimerization of NhaA, whereas NapA has adapted to form an interface that is stable without lipids. Overall, by correlating interfacial strength with the presence of interfacial lipids, we provide a rationale for understanding the role of lipids in both transient and stable interactions within a range of α-helical membrane proteins, including G-protein-coupled receptors.
The recent surge in structure determination of membrane proteins is providing details of protein-lipid binding 6 and yielding insight into the regulatory roles of lipids 7, 8 . The advent of methods using mass spectrometry to characterize membrane proteins individually 9 , within interactomes 10 and in intact assemblies 11 is contributing to our understanding of the potential roles of lipids in inducing conformational changes 12 , contributing to activity and modulating drug efflux (reviewed in ref. 13 ). The role of lipids in maintaining the oligomeric state of membrane proteins has, however, remained widely debated. To understand this phenomenon we performed a bioinformatic analysis of all of the α -helical oligomeric transmembrane proteins with known structures. To gauge their relative stability, we ranked these oligomers according to the buried surface area between the interfaces and the number of salt-bridge interactions (Fig. 1) , with a higher buried surface area and number of salt bridges indicating higher stability 14 (Fig. 1 ). On examination of 12 membrane proteins for which we predicted high oligomeric stability, mass spectra revealed that their actual masses were in agreement with their oligomeric masses, devoid of additional lipids ( Fig. 1 . A mass spectrum recorded following liberation of LeuT from octylglucoside micelles reveals it to be a dimer (Fig. 2) . The mass of the dimer was consistently greater than that of twice the monomeric mass of 59.3 kDa (126.0 kDa = 2 × 59.3 + 7.4 kDa) over numerous preparations (see Methods), with different constructs and collision energies, indicative of the noncovalent binding of small molecules with high affinity and precise stoichiometry (Extended Data Fig. 1 ). Incubation of LeuT in neopentyl glycol, a detergent with high delipidation properties 16 , and reconstitution into octylglucoside followed by mass spectrometry, revealed exclusively monomeric LeuT (Extended Data Fig. 2a-c) . The addition of E. coli polar lipids to delipidated monomeric LeuT, in octylglucoside, Protein oligomers are represented by circles colour-coded according to the number of salt bridges they form, where maximum number of salt bridge is designated to 100% and 0 is marked as 0% and are grouped by oligomeric state (pentamers+ have an oligomeric state ≥ 5). A random horizontal jitter has been applied to all points to aid visualization. NhaA and LeuT (outlined in red) are two of the weakest oligomers, having some of the lowest buried surface areas and forming no salt bridges. The 12 proteins for which mass spectra have been recorded are outlined in green. Illustrated are mass spectra of the trimeric ammonia channel AmtB, tetrameric aquaporin AqpZ and pentameric ion channel ELIC. A larger buried surface area than LeuT and NhaA but an absence of salt bridges make SemiSWEET a stronger dimer than LeuT and NhaA but weaker than the other 12 oligomeric proteins.
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recovered a significant population of the dimer (Extended Data  Fig. 2d ). These observations imply that the additional mass associated with the dimer is comprized of lipid.
Conventional lipid-identification experiments require the extraction of lipids from the proteo-micelle solution or cellular environment, followed by either a chromatographic or mass spectrometry step 17, 18 . These approaches report on the entire set of lipids present but fail to distinguish endogenous lipids bound to the membrane protein of interest from those in bulk solution. Simultaneous identification of the bound lipids and the oligomeric state of the protein requires a tandem mass spectrometry (MS/MS) platform, akin to protocols developed to sequence peptides in top-down proteomics 19 . MS/MS in its current form cannot be applied to membrane proteins directly since the activation energy available in the collision cell is used to liberate membrane proteins from detergent micelles 20 . To overcome this problem, we developed an instrument platform in which the high energy applied at the source region removes the detergent micelle before entry into the collision cell, enabling isolation of discrete lipid-bound complexes in the quadrupole for subsequent MS/MS and lipid identification (Fig. 2a) . Using this platform, we isolated the 23+ charge state of the dimer that incorporates the 7.4 kDa of additional mass (Fig. 2c) . Activation of this species in the collision cell yields monomeric LeuT in the apo and lipid-bound states, with one cardiolipin molecule and up to three phospholipids. Increasing the collision energy results in the monomer retaining one cardiolipin molecule (Extended Data Fig. 3 ), enabling us to distinguish the binding of one cardiolipin from the potential binding of two phospholipids. It is important to emphasize that all ions present in the MS/MS spectrum originate from dimeric LeuT parent ions with the additional 7.4 kDa, which can now be assigned to three phospholipids and one cardiolipin per subunit (3.7 kDa or 7.4 kDa per dimer).
Production of wild-type LeuT in a cardiolipin-deficient E. coli strain yielded exclusively delipidated monomeric LeuT (Extended Data Fig. 4) , confirming that cardiolipin is essential for dimerization. Performing coarse-grained molecular dynamics (CGMD) simulation of the LeuT dimer in a bilayer revealed binding of cardiolipins and phospholipids at the dimer interface. Each cardiolipin interacts with both monomeric units, with its bi-phosphate head group binding to basic residues (K376, H377 and R506) on either side of the dimer interface ( Fig. 2c and Extended Data Figs 4, 5). These results help to identify the residues that form critical contacts with lipid head-groups to confer the specificity of these interactions. Substitution to alanine of either the dimer-interface residues or the basic residues that bind to cardiolipin, abolished dimer formation (Extended Data Fig. 4) . We conclude that LeuT has a weak dimer interface that is stabilized by cardiolipin, which bridges the interface and is augmented by six phospholipids.
The bacterial sugar transporter SemiSWEET from V. splendidus is a functional dimer 5 . A combination of the buried surface area and absence of salt-bridge interactions between monomers makes SemiSWEET an example of an oligomer with stability higher than LeuT but considerably lower than the 12 strong oligomers considered above. The mass spectrum of SemiSWEET shows the presence of both monomer and dimer species (Extended Data Fig. 6a ). To investigate whether the presence of monomers is a consequence of lipid removal during protein purification and whether the monomers are in equilibrium with the dimers, we prepared two mass-distinct forms of 
SemiSWEET (with or without a deca-His tag, Extended Data Fig. 6 ).
A time-course mass spectrometry experiment, subsequent to mixing of these two mass-distinct forms in equal ratios, revealed the rapid appearance of heterodimeric peaks, consistent with a solution-phase monomer-dimer equilibrium (Extended Data Fig. 6 ). High-energy MS/MS of SemiSWEET also identified endogenous bound lipids, a significant proportion of which were cardiolipin (Extended Data Fig. 6c ). Upon the addition of increasing amounts of cardiolipin, we observed preferential lipid binding to the dimer and a subsequent shift in the equilibrium towards the dimeric population (Fig. 3) . By contrast, addition of phosphatidylglycerol revealed no such preference towards any oligomeric forms (Extended Data Fig. 6d ). We therefore conclude that the preferential binding of lipid to the dimer drives the equilibrium towards the functionally relevant state of the protein.
Given our emerging hypothesis-that lipids are critical for stabilizing weak dimer interfaces-we sought to compare proteins with weak interfaces that might require lipids for dimerization to homologues with higher interface strengths. One such pair of proteins is the NhaA and NapA Na + /H + antiporters, from E. coli and T. thermophilus, respectively ( Fig. 1) . Although the oligomeric stability of dimeric NhaA is comparable to that of LeuT, our interface analysis suggests that dimeric NapA is likely to be more stable (Fig. 4) . The mass spectrum of NhaA reveals an ensemble of lipid-bound dimeric species (Fig. 4a ) and a complete absence of delipidated dimer. Performing MS/MS on the lipidbound NhaA dimer leads to stepwise losses of cardiolipin and yields monomers with one cardiolipin bound as well as an apo NhaA dimer that readily dissociates (Extended Data Fig. 7 ). The appearance of monomeric NhaA is coincident with the loss of the second cardiolipin, suggesting that cardiolipin stabilizes the dimer structure. Molecular dynamics simulations of NhaA in a lipid box reveal that cardiolipin can bind at the interface, further supporting the observed role of cardiolipin in stabilization ( Fig. 4a and Extended Data Fig. 5 ). Mass spectrometry analysis of the homologous NapA revealed a marked contrast; the NapA dimer is completely lipid-free, confirming its intrinsic stability in the absence of interfacial lipids. This is consistent with the known higher stability of the proteins of thermophiles than their nonthermophilic homologues. In NapA, an additional N-terminal helix that is absent from NhaA strengthens the protein-protein interface, essentially removing the requirement for lipids to stabilize dimer formation. These two proteins, which were purified from identical membranes and share the same fold and physiological role, demonstrate that membrane proteins can either acquire additional structural elements to ensure greater contacts between subunits or recruit lipids to preserve their oligomeric state.
We anticipate that the ability to form a stable interface or to recruit lipids to preserve oligomeric state might be a general phenomenon that exists in other membrane protein systems such as G-protein-coupled receptors (GPCRs) 21 . When estimating the oligomeric strength of the two possible interfaces of μ -opioid receptor, we see that the transmembrane helix 5 (TM5)-TM6 and TM1/TM2-H8 interfaces have buried surface areas of 1,585.6 Å 2 and 588.0 Å 2 , respectively, both without salt bridges. We therefore estimate that the TM1/TM2-H8 interface is considerably weaker 22 (Fig. 4b) . However, the tighter interface (TM5-TM6) restricts the conformational flexibility required to attain 
the agonist-bound state 23 . The weaker interface contains a cavity, akin to that found in NhaA, wherein a side chain of a fatty acid has been modelled in the crystal structure 23 . The weak dimeric interfaces involving TM1/TM2-H8 can also be constructed for many other GPCRs, including the β 1 adrenergic receptor and κ -opioid receptors, which have buried surface areas of 833.6 Å 2 and 1025.1 Å 2 , respectively, both without salt bridges (Fig. 4b) . These very low oligomeric strengths are consistent with observations of transient oligomeric states 24 , leading us to speculate that much of the controversy surrounding the oligomeric state of GPCRs stems from their ability to exist in multiple forms, with different interfaces modulated by interfacial lipids, analogous to the monomer-dimer equilibrium shown here for SemiSWEET.
Although the intrinsic stability of the oligomers correlates with lipid binding to stabilize interfaces, a key question arises with respect to function. For both SemiSWEET and NhaA, the existence of a stable dimeric state is thought to be critical for their mechanistic pathways 25 . Under conditions of extreme stress, the dimer of NhaA is more functionally active than the monomer 26 . By analogy with LeuT, dimerization of the homologous eukaryotic dopamine and serotonin transporters (DAT and SERT, respectively) might also be anticipated in vivo 27, 28 . Sequence alignment and superposition of the structures of LeuT and SERT reveal that the cardiolipin-binding residues identified here are conserved in all biogenic amine transporters (Extended Data Fig. 8 ). A key difference between the X-ray crystallographic structures of LeuT and SERT arises in the C-terminal helix of SERT, which orients away from the subunit interface, preventing dimerization in the crystal form 29 . Nevertheless, the functional significance of dimers (and possibly higher oligomers) of SERT is well documented 30 . Overall our data show how lipid-binding at interfaces stabilizes weak oligomers and provide direct and compelling evidence that altering the lipid composition in solution can propagate changes in oligomeric state. In the cellular environment, such mechanisms are likely to be employed to regulate the abundance of functional forms of membrane proteins. As new structures of membrane proteins emerge, the approach described here can help to resolve conflicts in oligomeric state and contribute to our understanding of their functional relevanceimportant considerations for the design of bio-therapeutics and for drug targeting.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Supplementary Information is available in the online version of the paper.

METHODS
Molecular cloning and plasmid construction.
LeuT was expressed from a pET16b vector, containing a thrombin-cleavable C-terminal 8× His tag. SemiSWEET was expressed from a pJexpress411 vector, containing a HRV-3C protease cleavable 10× His-tag. All point mutations were generated using a Quikchange Lightning site-directed mutagenesis kit, according to the manufacturer's protocol. For expression of LeuT in the cardiolipin-deficient BKT22 E. coli strain 31 the LeuT gene was amplified by PCR using a Phusion Flex Hot Start Polymerase (New England Biolabs) with primers designed for Infusion cloning using the manufacturer's online tool. The PCR product was purified using gel agarose electrophoresis, then used in an Infusion cloning reaction (Clontech) with a linearized pBAD vector containing a 10× His tag. The LeuT-eYFP fusion protein was expressed from a pET-15b/pET-23b hybrid vector, containing the LeuT gene followed by a TEV protease cleavage site, the eYFP gene (with mutation A206K to abolish eYFP dimerization) and a 6× His tag. To construct this plasmid, the LeuT gene was amplified by PCR as above and used in an infusion reaction with a pET-15b/pET-23b hybrid vector 12 cut with appropriate restriction enzymes, and a synthetic gene block (IDT) containing the TEV site and eYFP gene. All plasmid constructs were confirmed by DNA sequencing. Membrane protein expression and purification. The LeuT plasmid was transformed into C43 E. coli (Lucigen), and expressed and purified as reported previously 32 . In brief, multiple colonies were used to inoculate 100 ml of terrific broth (TB) and were grown overnight at 37 °C. A total of 10 ml of overnight culture was used to inoculate each of 6 l of TB, which were allowed to grow at 37 °C until the culture reached an A 600 of 0.6. Isopropyl β -d-thiogalactopyranoside (IPTG) was added to a final concentration of 0.1 mM, and the cultures grown for 16 h at 20 °C. Cells were harvested by centrifugation at 5,000g for 10 min at 4 °C, resuspended in lysis buffer solution (300 mM sodium chloride, 20 mM Tris; pH 7.4) supplemented with protease inhibitor cocktail (Roche) and lysed using a M-110 PS microfluidizer (Microfluidics), and the cell debris was pelleted by centrifugation at 20,000g for 25 min at 4 °C. Membranes were pelleted by centrifugation of the supernatant at 100,000g for 2 h at 4 °C and subsequently resuspended in ice-cold buffer soluition (100 mM sodium chloride, 20 mM Tris, 20% glycerol; pH 8.0) and homogenized using a Potter-Elvehjem Teflon pestle and glass tube. n-dodecyl β -d-maltopyranoside (DDM) was added to resuspended membranes to a final concentration of 2% (w/v) and the suspension incubated with gentle agitation for 15 h at 4 °C. Insoluble material was pelleted by centrifugation at 20,000g for 30 min and the supernatant filtered through 0.22-μ m filters. LeuT was purified by immobilized-metal ionaffinity chromatography using a HisTrap HP 5-ml column (GE healthcare) equilibrated with buffer A (190 mM sodium chloride, 10 mM potassium chloride, 20 mM Tris, 20 mM imidazole, 10% glycerol, 0.02% DDM; pH 8.0) and eluted with buffer B (190 mM sodium chloride, 10 mM potassium chloride, 20 mM Tris, 500 mM imidazole, 10% glycerol, 0.02% DDM; pH 8.0). The eluted protein was transferred to a dialysis cassette (100 kDa molecular weight cut-off) and dialysed against a dialysis buffer solution (190 mM sodium chloride, 10 mM potassium chloride, 20 mM Tris, 10% glycerol; pH 8.0) with 0.02% DDM overnight. A 100-kDa molecular weight cut-off (MWCO) concentrator was used to concentrate the dialysed protein. LeuT was then injected onto a Superdex 200 Increase GL 10/300 column (GE Healthcare), equilibrated in a buffer (190 mM sodium chloride, 10 mM potassium chloride, 20 mM Tris,10% glycerol; pH 8.0) with 1% octylglucoside. Peak fractions containing octylglucoside-solubilized LeuT were concentrated as above and used for further study. All protein concentration measurements were carried out using a UV/vis spectrophotometer (DS-11 + , DeNovix). The mass addition to the wild-type LeuT was observed over seven different preparations.
The V. splendidus SemiSWEET plasmid was transformed into BL21 DE3 E. coli (Novagen), and expressed and purified as reported previously 5 . In brief, multiple colonies were used to inoculate 100 ml of LB and grown overnight at 37 °C. A total of 10 ml of overnight culture was used to inoculate each of 6 l of LB, which were allowed to grow at 37 °C until the culture reached an A 600 of 0.8. IPTG was added to a final concentration of 0.2 mM, and the culture grown for 15 h at 22 °C. Cell harvesting, resuspension, lysis, membrane isolation and detergent extraction steps were identical to the LeuT purification. SemiSWEET was first purified by IMAC using a HisTrap HP 5 ml column (GE healthcare) equilibrated with buffer A (150 mM sodium chloride, 20 mM Tris, 20 mM imidazole, 10% glycerol, 1 mM DTT, 0.02% DDM; pH 8.0) and eluted with Buffer B (150 mM sodium chloride, 20 mM Tris, 500 mM imidazole, 10% glycerol, 1 mM DTT, 0.02% DDM; pH 8.0). The eluted protein and HRV 3C protease (Novagen) were transferred to a dialysis cassette (30 kDa MWCO), and dialysed against buffer (150 mM sodium chloride, 20 mM Tris, 10% glycerol, 1 mM DTT; pH 8.0) with 0.02% DDM overnight. For preparation of 10× His-tagged SemiSWEET, no HRV 3C protease was added to the dialysis cassette. A 50-kDa MWCO concentrator was used to concentrate the dialysed protein. SemiSWEET was then injected onto a Superdex 200 Increase GL 10/300 column (GE Healthcare), equilibrated in a buffer solution (150 mM sodium chloride, 20 mM Tris, 10% glycerol, 1 mM DTT, 0.02% DDM; pH 8.0) with 0.5% C 8 E 4 . Peak fractions containing C 8 E 4 -solubilized SemiSWEET were concentrated as above and used for further study.
NapA, NhaA, AqpZ, AmtB and ELIC were expressed as described previously 12, [33] [34] [35] . Non-denaturing mass spectrometry. Samples were prepared for non-denaturing mass spectrometry by buffer-exchange into mass spectrometry buffer (200 mM ammonium acetate, 2× critical micelle concentration of detergent of interest; pH 7.4) using a centrifugal buffer exchange device (Micro Bio-Spin, Biorad). For SemiSWEET experiments, 1 mM DTT was also added to the mass spectrometry buffer.
Mass spectrometry measurements were performed on a Synapt G1(Waters) with a Z-spray source, using nanoelectrospray capillaries prepared in-house 36 . The source pressure was set to 4-7 mBar, with a capillary voltage of 1.4-1.7 kV, capillary nanoflow of 0.05-0.2 mBar and argon as collision (trap) gas at flow rate of 1.5-8.0 ml min −1
. Other parameters, including the sample and extraction cone and trap bias voltages, collision voltages and quadrupole profile were optimized for maximal ion intensity and minimal dissociation of the target membrane protein complex. Data were processed using MassLynx software. High-energy non-denaturing mass spectrometry. To allow the use of higher voltages on the extraction cone in the source region of the Synapt G2, the configuration file for the extraction cone was modified to increase the maximum voltage setting from 10 V to 200 V. However, altering this setting alone would restrict the maximum sample cone voltage that could be accessed owing to the limits imposed by the power supplies. To overcome this limitation, the capability to drive the sample cone voltage from an external supply was implemented. This took the form of a patch cable introduced between the instrument lens control PCB and the source ion block. The ion block contains both heater elements and a thermocouple in addition to supporting the extraction cone and these were decoupled with the patch cable to prevent possible electrical breakdown with use of higher cone voltages. The extraction cone was patched directly through from the lens PCB while the sample cone voltage was decoupled and a new wire connection made to an external power supply. Delipidation. Purified, octylglucoside-solubilized LeuT was incubated in 2% neopentyl glycol overnight at 4 °C. Subsequently, the sample was passed through a Superdex 200 Increase GL 10/300 column (GE Healthcare) equilibrated in 200 mM ammonium acetate with twice the critical micelle concentration of neopentyl glycol, to remove the excess octylglucoside and neopentyl glycol. This sample was subjected to mass spectrometric analysis. The delipidated LeuT in neopentyl glycol was re-exchanged back in octylglucoside using the above protocol with, the 200 mM ammonium acetate containing 1% octylglucoside. E. coli polar lipid stocks were made from powder (Avanti Polar Lipids Inc.) at a concentration of 10 mg ml −1 using previously published methods 12 and subsequently diluted 50 times in 200 mM ammonium acetate solution containing 1% octylglucoside. A dilyso-cardiolipin stock (10 mg ml −1 in 200 mM ammonium acetate) was prepared as described previously 35 ; aliquots of this stock were diluted 50 times in 200 mM ammonium acetate solution containing 1% octylglucoside for each mass spectrometry experiment. Preparation and titration of phospholipids. Purified SemiSWEET-His 10 in mass spectrometry buffer was diluted to an oligomer concentration of 20 μ M. A cardiolipin stock (10 mg ml −1 in 200 mM ammonium acetate) was prepared as described previously 35 ; aliquots of this stock were diluted in mass spectrometry buffer to a cardiolipin concentration 2× that required for each mass spectrometry experiment. Diluted SemiSWEET and cardiolipin solutions were then mixed 1:1 and incubated on ice for 5 min (for the measurement without cardiolipin, SemiSWEET was mixed with mass spectrometry buffer). Following this, 2 μ l of the mixture was used for each of three mass spectrometry measurements at the 4 lipid concentrations.
Data was acquired for 100 scans, which were summed in MassLynx software and processed using UniDec deconvolution software 37 . Relative monomer and dimer abundances were calculated by taking the sum of the respective deconvoluted intensities in all lipidation (and non-lipidated) states, normalized to the total intensity of all SemiSWEET species, and averaged over the three repeats (error bars in Fig. 3 are ± 1 s.d.) . A plot of relative monomer and dimer abundances against cardiolipin concentration was generated using SigmaPlot.
Mass spectrometry measurements were performed on a Synapt G1 as described above. The source pressure was set to 4.2 mBar, capillary nanoflow 0.1 mBar, trap collision voltage 50 V, transfer collision voltage 10 V and collision gas flow rate 1.8 ml min −1 . Subunit exchange. Purified, C 8 E 4 -solubilized SemiSWEET and SemiSWEET-His 10 were separately buffer-exchanged into mass spectrometry buffer as described above, then concentrated to 40 μ M using a 30-kDa MWCO concentrator. 3 μ l of
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SemiSWEET and SemiSWEET-His 10 were then mixed briefly on ice and 3 μ l of this equimolar mixture was immediately transferred to a nanoelectrospray capillary for mass spectrometry data acquisition. Data was acquired continuously for 10 min.
Data were processed using Xcalibur software (Thermo Scientific) as follows: spectra were extracted from summation of the chromatogram in 30-s scan windows centred on each minute (for example, 0.75-1.25 min for the 1-min time point). Relative abundances of the SemiSWEET and SemiSWEET-His 10 homodimers and the SemiSWEET.SemiSWEET-His 10 heterodimer were calculated for each time point using UniDec. A plot of relative homodimer abundance and heterodimer abundance against time was generated using SigmaPlot.
Mass spectrometry measurements were performed on a modified Q-Exactive orbitrap mass spectrometer (Thermo Fisher) 38 modified and optimized for non-denaturing mass spectrometry of membrane protein complexes. Spectra were acquired in 'Native Mode' with maximum radio frequency applied to all ion optics, − 3.2 kV to the central electrode of the Orbitrap and with ion trapping in the higher-energy collisional dissociation (HCD) cell. Ions were generated in positive ion mode from a static nanospray source using gold-coated capillaries prepared in-house. Transient times were 64 ms and AGC target was 1 × 10 6 . Spectra were acquired with 1 microscan, a noise-level parameter set to 3 and HCD cell voltage of 75 V; no in-source activation was applied. The collision gas was argon and pressure in the HCD cell was maintained at approximately 1 × 10 −9 mbar. Molecular dynamics simulations. All molecular dynamics simulations were performed using GROMACS v5.1.2 (ref. 39 ). The MemProtMD pipeline 40 was used with the Martini 2.2 force field 41 to run five repeats of a 1-μ s CGMD simulation of the dimeric protein complexes. The last 800 ns of each of these simulation trajectories were considered for further analysis. The proteins were centred within the simulation system to permit the assembly and equilibration of 10% cardiolipin either with a 20%:70% ratio of 1-palmitoly, 2-oleoyl, phosphatidylglycerol (POPG) to 1-palmitoyl, 2-oleoyl, phosphatidylethanolamine (POPE), or with 90% 1-palmitoyl, 2-oleoyl, phosphatidylcholine (POPC) bilayers. Systems were neutralized with a 150 mM concentration of NaCl. All simulations were performed at 323 K, with protein, lipids and solvent separately coupled to an external bath using the velocityrescale thermostat 42 . Pressure was maintained at 1 bar with a semi-isotropic compressibility of 5 × 10 −6 using the Berendsen barostat 43 . All bonds were constrained with the P-LINCS algorithm 44 . Electrostatics was measured using the 'reaction field' method 45 , while a Verlet cut-off scheme to permit GPU calculation of non-bonded contacts was used for Lennard-Jones parameters 46 . Simulations were performed with an integration time-step of 20 fs. Atomistic snapshots at the end-point of the CGMD simulations were created using CG2AT 47 in combination with Alchembed 48 . The lipid densities and contacts with the protein during the molecular dynamics simulations were calculated using MDAnalysis 49 , and locally written code. All images and animations were generated using Pymol 50 . Estimation of oligomeric stability. A database of integral oligomeric membrane proteins for which crystal structures have been obtained was created from the MPStruc database (http://blanco.biomol.uci.edu/mpstruc/). For each class of proteins, one homologue was chosen. Subsequently, the buried surface area and the number of salt-bridge interactions were calculated using PDBePISA webserver 51 . The total buried surface and the number of salt bridge values were visualized using a scatter generated using the Matplotlib library for the Python programming language. Superimposed on this is a circle for each protein, whose vertical position was determined by its buried surface area of the complex and blocked as per oligomeric state. Each circle was further colour coded based on the number of salt bridges present in the complex. To reduce overlap of points, an arbitrary horizontal jitter (sampled randomly from a uniform distribution) was applied to each point. LeuT-SERT structure alignment. The structure of LeuT (PDB ID 2A65) and SERT (PDB ID 5I6Z) were superimposed using PyMOL and the sequence alignment of LeuT with the BATs were done using Clustal Omega (http://www.ebi. ac.uk/Tools/msa/clustalo/). The individual sequences were obtained from Uniprot (http://www.uniprot.org/).
Data availability. The raw data for Fig. 1 Figure 4 | Site-directed mutagenesis of selected residues at the LeuT dimer interface, resulting mass spectra and molecular dynamics simulations. a, Mass spectrum of LeuT F488A/Y489A, liberated from octylglucoside micelles, reveals monomeric LeuT (green spheres). Inset shows the LeuT dimer interface, with key π -stacking interactions (yellow dotted lines, distances labelled in red) and between aromatic residues (purple). When residues F488 and Y489 (orange arrows) are mutated to alanine, the π -stacking interactions are abolished and LeuT cannot dimerize. b, Molecular dynamics simulations of LeuT in an E. coli lipid bilayer reveal possible binding sites of interfacial phospholipids and cardiolipin (upper panel, viewed from cytoplasmic side of membrane). The cardiolipin phosphate groups (orange) interact closely with positively charged residues (K376, H377, R506; blue) at the dimer interface. Phosphoethanolamine (PE) and phosphatidylglycerol (PG) also bind at the dimer interface. c, Mass spectrum of LeuT expressed in a cardiolipindeficient E. coli strain (BKT22), liberated from octylglucoside micelles, shows monomeric LeuT, implying that cardiolipin is required for LeuT dimerization. d, Mass spectrum of LeuT K376A/H377A, liberated from octylglucoside micelles, shows monomeric LeuT.
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